Hyun-Ju Doh

Title: Hyun-Ju Doh: Innovator in Monoclonal Antibody Research

Introduction

Hyun-Ju Doh is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, her work is paving the way for advancements in diagnostic agents.

Latest Patents

Hyun-Ju Doh's latest patents include a monoclonal antibody against D-dimer and methods of use therefor. This invention discloses a monoclonal antibody against human D-dimer produced in a mouse, along with high molecular weight cross-linked fibrin that includes a corresponding epitope. The patent details a cell line that secretes the monoclonal antibody and methods for producing it. The anti-D-dimer monoclonal antibody can be effectively used as a diagnostic agent for screening and detecting in-vivo D-dimer, as well as high molecular weight cross-linked fibrin and its derivatives. This antibody specifically reacts with D-dimer and cross-linked fibrin, which do not bind to human fibrinogen or fibrin.

Career Highlights

Throughout her career, Hyun-Ju Doh has focused on innovative research that addresses critical health issues. Her work has the potential to enhance diagnostic capabilities in medical settings, particularly in the detection of conditions related to D-dimer levels.

Collaborations

Hyun-Ju Doh has collaborated with notable colleagues, including Doo-Sik Kim and Kwang-Hoe Chung. These partnerships have contributed to the advancement of her research and the successful development of her patents.

Conclusion

Hyun-Ju Doh is a key figure in the field of monoclonal antibody research, with her innovative patents offering promising solutions for medical diagnostics. Her contributions are significant in advancing healthcare technologies and improving patient outcomes.